Risk Stratification for Seasonal Coronavirus Infections in HCT Recipients: Advances and Challenges

Transplant Infectious DiseaseVolume 0, Issue 0 e70096 EDITORIAL Risk Stratification for Seasonal Coronavirus Infections in HCT Recipients: Advances and Challenges Chikara Ogimi, Chikara Ogimi Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan Contribution: Conceptualization, Writing - original draft, Writing - review & editingSearch for more papers by this authorAlpana Waghmare, Corresponding Author Alpana Waghmare [email protected] orcid.org/0000-0003-2268-9470 Division of Infectious Diseases, Department of Pediatrics, University of Washington, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA Contribution: Conceptualization, Writing - original draft, Writing - review & editingSearch for more papers by this author Chikara Ogimi, Chikara Ogimi Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan Contribution: Conceptualization, Writing - original draft, Writing - review & editingSearch for more papers by this authorAlpana Waghmare, Corresponding Author Alpana Waghmare [email protected] orcid.org/0000-0003-2268-9470 Division of Infectious Diseases, Department of Pediatrics, University of Washington, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA Contribution: Conceptualization, Writing - original draft, Writing - review & editingSearch for more papers by this author First published: 21 August 2025 https://doi.org/10.1111/tid.70096Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechatBluesky No abstract is available for this article. References 1M. Hakki, R M. Rattray, and R D. Press, "The Clinical Impact of Coronavirus Infection in Patients With Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients," Journal of Clinical Virology 68 (2015): 1–5, https://doi.org/10.1016/j.jcv.2015.04.012. 10.1016/j.jcv.2015.04.012 PubMed Web of Science® Google Scholar 2C. Ogimi, A. A. Waghmare, J. M. Kuypers, et al., "Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples from Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies," Clinical Infectious Diseases 64, no. 11 (2017): 1532–1539, https://doi.org/10.1093/cid/cix160. 10.1093/cid/cix160 CAS PubMed Web of Science® Google Scholar 3C. Ogimi, H. Xie, A. Waghmare, et al., "Risk Factors for Seasonal Human Coronavirus Lower Respiratory Tract Infection After Hematopoietic Cell Transplantation," Blood Advances 5, no. 7 (2021): 1903–1914, https://doi.org/10.1182/bloodadvances.2020003865. 10.1182/bloodadvances.2020003865 CAS PubMed Web of Science® Google Scholar 4J. L. Piñana, A. Xhaard, G. Tridello, et al., "Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation," Journal of Infectious Diseases 223, no. 9 (2021): 1564–1575, https://doi.org/10.1093/infdis/jiaa553. 10.1093/infdis/jiaa553 CAS PubMed Web of Science® Google Scholar 5F. Khawaja, T. L. Shigle, L. Yaghi, et al., "Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients" Transplant Infectious Diseases (forth coming). Google Scholar 6D. P. Shah, S. S. Ghantoji, E. J. Ariza-Heredia, et al., "Immunodeficiency Scoring Index to Predict Poor Outcomes in Hematopoietic Cell Transplant Recipients With RSV Infections," Blood 123, no. 21 (2014): 3263–3268, https://doi.org/10.1182/blood-2013-12-541359. 10.1182/blood-2013-12-541359 CAS PubMed Web of Science® Google Scholar 7C. Ogimi, H. Xie, A. Waghmare, et al., "Correction: Novel Factors to Predict Respiratory Viral Disease Progression in Allogeneic Hematopoietic Cell Transplant Recipients," Bone Marrow Transplantation 59, no. 12 (2024): 1790, https://doi.org/10.1038/s41409-024-02418-9. 10.1038/s41409-024-02418-9 PubMed Google Scholar 8T. Matsui and C. Ogimi, "Risk Factors for Severity in Seasonal Respiratory Viral Infections and How They Guide Management in Hematopoietic Cell Transplant Recipients," Current Opinion in Infectious Diseases 36, no. 6 (2023): 529–536, https://doi.org/10.1097/QCO.0000000000000968. 10.1097/QCO.0000000000000968 CAS PubMed Web of Science® Google Scholar 9E. M. Eichenberger, R. Soave, D. Zappetti, et al., "Incidence, Significance, and Persistence of Human Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients," Bone Marrow Transplantation 54, no. 7 (2019): 1058–1066, https://doi.org/10.1038/s41409-018-0386-z. 10.1038/s41409-018-0386-z CAS PubMed Web of Science® Google Scholar 10C. J. Wiedermann, "Hypoalbuminemia as Surrogate and Culprit of Infections," International Journal of Molecular Sciences 22, no. 9 (2021): 4496, https://doi.org/10.3390/ijms22094496. 10.3390/ijms22094496 CAS PubMed Web of Science® Google Scholar Volume0, Issue0e70096 ReferencesRelatedInformation